RSVPreF3 OA vaccine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-30 in 2mo
ESTIMATED |
READOUT
An Extension and Crossover Vaccination Study on the Immune Response and Safety o
Phase 3 · Respiratory Syncytial Virus Infections |
GlaxoSmithKline | RSVPreF3 OA vaccine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|